Literature DB >> 30883057

Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.

Jorrit S Lemkes1, Gladys N Janssens1, Nina W van der Hoeven1, Lucia S D Jewbali1, Eric A Dubois1, Martijn Meuwissen1, Tom A Rijpstra1, Hans A Bosker1, Michiel J Blans1, Gabe B Bleeker1, Rémon Baak1, Georgios J Vlachojannis1, Bob J W Eikemans1, Pim van der Harst1, Iwan C C van der Horst1, Michiel Voskuil1, Joris J van der Heijden1, Albertus Beishuizen1, Martin Stoel1, Cyril Camaro1, Hans van der Hoeven1, José P Henriques1, Alexander P J Vlaar1, Maarten A Vink1, Bas van den Bogaard1, Ton A C M Heestermans1, Wouter de Ruijter1, Thijs S R Delnoij1, Harry J G M Crijns1, Gillian A J Jessurun1, Pranobe V Oemrawsingh1, Marcel T M Gosselink1, Koos Plomp1, Michael Magro1, Paul W G Elbers1, Peter M van de Ven1, Heleen M Oudemans-van Straaten1, Niels van Royen1.   

Abstract

BACKGROUND: Ischemic heart disease is a major cause of out-of-hospital cardiac arrest. The role of immediate coronary angiography and percutaneous coronary intervention (PCI) in the treatment of patients who have been successfully resuscitated after cardiac arrest in the absence of ST-segment elevation myocardial infarction (STEMI) remains uncertain.
METHODS: In this multicenter trial, we randomly assigned 552 patients who had cardiac arrest without signs of STEMI to undergo immediate coronary angiography or coronary angiography that was delayed until after neurologic recovery. All patients underwent PCI if indicated. The primary end point was survival at 90 days. Secondary end points included survival at 90 days with good cerebral performance or mild or moderate disability, myocardial injury, duration of catecholamine support, markers of shock, recurrence of ventricular tachycardia, duration of mechanical ventilation, major bleeding, occurrence of acute kidney injury, need for renal-replacement therapy, time to target temperature, and neurologic status at discharge from the intensive care unit.
RESULTS: At 90 days, 176 of 273 patients (64.5%) in the immediate angiography group and 178 of 265 patients (67.2%) in the delayed angiography group were alive (odds ratio, 0.89; 95% confidence interval [CI], 0.62 to 1.27; P = 0.51). The median time to target temperature was 5.4 hours in the immediate angiography group and 4.7 hours in the delayed angiography group (ratio of geometric means, 1.19; 95% CI, 1.04 to 1.36). No significant differences between the groups were found in the remaining secondary end points.
CONCLUSIONS: Among patients who had been successfully resuscitated after out-of-hospital cardiac arrest and had no signs of STEMI, a strategy of immediate angiography was not found to be better than a strategy of delayed angiography with respect to overall survival at 90 days. (Funded by the Netherlands Heart Institute and others; COACT Netherlands Trial Register number, NTR4973.).
Copyright © 2019 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2019        PMID: 30883057     DOI: 10.1056/NEJMoa1816897

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  71 in total

1.  Focus on post-resuscitation care.

Authors:  Claudio Sandroni; Alain Combes; Jerry P Nolan
Journal:  Intensive Care Med       Date:  2019-06-25       Impact factor: 17.440

Review 2.  Highlights from the 2019 American College of Cardiology Scientific Sessions in New Orleans, LA.

Authors:  Dylan L Steen
Journal:  J Thromb Thrombolysis       Date:  2019-07       Impact factor: 2.300

3.  [It's a question of timing-does every patient with NSTEMI require immediate coronary angiography?]

Authors:  Christoph Adler; Stephan Baldus
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-01-11       Impact factor: 0.840

Review 4.  [ESC guidelines 2020: acute coronary syndrome without persistent ST-segment elevation : What is new?]

Authors:  Holger Thiele; Alexander Jobs
Journal:  Herz       Date:  2021-02       Impact factor: 1.443

5.  Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.

Authors:  Ashwin S Nathan; Qun Xiang; Daniel Wojdyla; Sameed Ahmed M Khatana; Elias J Dayoub; Rishi K Wadhera; Deepak L Bhatt; Daniel M Kolansky; Ajay J Kirtane; Sunil V Rao; Robert W Yeh; Peter W Groeneveld; Tracy Y Wang; Jay Giri
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

6.  Unsupervised learning of early post-arrest brain injury phenotypes.

Authors:  Jonathan Elmer; Patrick J Coppler; Teresa L May; Karen Hirsch; John Faro; Pawan Solanki; McKenzie Brown; Jacob S Puyana; Jon C Rittenberger; Clifton W Callaway
Journal:  Resuscitation       Date:  2020-06-09       Impact factor: 5.262

Review 7.  After COACT trial-new perspectives for the management of non-ST elevation myocardial infarction: early versus late cardiac catheterization post cardiac arrest.

Authors:  Miguel A Maturana; Charles F Clinton; Selene Caballero-Cummings; Brandon Cave; Amal Khan; Amit Nanda; Devarshi Ardeshna; Joel Raja; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2019-09

8.  Immediate angiography does not improve outcomes after OHCA without STEMI.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

9.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care.

Authors:  Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar
Journal:  Intensive Care Med       Date:  2021-03-25       Impact factor: 17.440

Review 10.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.